Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer - Related Studies

Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

This study has been completed.

Study NCT00030433. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Lung Cancer

2	Additional conditions recognized in this trial
		Carcinoma, Small Cell
		Lung Neoplasms

3	More general conditions related to this trial
		Adenocarcinoma
		Carcinoma
		Carcinoma, Neuroendocrine
		Lung Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Glandular and Epithelial
		Neoplasms, Nerve Tissue
		Neuroectodermal Tumors
		Neuroendocrine Tumors
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Thoracic Neoplasms

4	Interventions listed in this trial
		gemcitabine hydrochloride
		irinotecan hydrochloride

5	Additional drug interventions recognized in this trial
		Camptothecin
		Gemcitabine
		Irinotecan

6	More general drug interventions related to this trial
		Anti-Infective Agents
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Antiviral Agents
		Enzyme Inhibitors
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		Southwest Oncology Group
		National Cancer Institute (NCI)